摘要 |
Compounds for treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the compounds are of formula (I):
where G, J, L, M, x, y, W, V, R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 8a , R 9 , R 9a , R 10 , R 10a , R 11 and R 11a are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed. |
申请人 |
XENON PHARMACEUTICALS INC. |
发明人 |
SVIRIDOV, SERGUEI;LIU SHIFENG;WINTHER, MICHAEL, D.;KAMBOJ, RAJENDER;HOLLADAY, MARK, W.;TU, CHI;KODUMURU, VISHNUMURTHY;ABREO, MELWYN;GSCHWEND, HEINZ, W.;SUN, SHAOYI;LI, WENBAO |